InVitro International (IVRO)
ValueMarkers Composite Index
78% below intrinsic value ($0)
InVitro International (IVRO) — VMCI valuation read
InVitro International sits at VMCI 57/100, with the Healthcare sector median at 50. That 7-point spread is the first thing to note on IVRO: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.
Form 4 disclosures on IVRO are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.
**Investor frame.** The Value read on IVRO: IVRO trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of -0.2x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.
IVRO rose 2.0% over the trailing 7 days, with a -1.2% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.